Benitec Biopharma(BNTC) - 2023 Q2 - Quarterly Report

During the year ended June 30, 2021, the Company completed an organization restructuring as part of the commercial desire to provide a more efficient structure for the future as the Company transitioned its operations to the United States. 2. Basis of Presentation and Summary of Significant Accounting Policies Principles of Consolidation Table of Contents There can be no assurance that the Company's research and development will be successfully completed, that adequate protection for the Company's intellect ...